Peripheral biomarkers associated with apathy and predicting response to methylphenidate: Secondary analysis of the Apathy in Dementia Methylphenidate Trial 2 (ADMET2) study
Inflammatory and neuronal injury biomarkers may have prognostic value and may potentially inform treatment response and remission outcomes in apathy. Apathy in Dementia Methylphenidate Trial 2 (ADMET2), NCT02346201, https://clinicaltrials.gov/study/NCT02346201.
Authors
- Ana C. Andreazza (ORCID: https://orcid.org/0000-0002-4323-7273)
- Krushnaa Sankhe (ORCID: https://orcid.org/0000-0003-0535-4935)
- Shankar Tumati (ORCID: https://orcid.org/0000-0001-5703-2044)
- Prasad R. Padala (ORCID: https://orcid.org/0000-0003-1921-9806)
- Olga Brawman‐Mintzer
- Alan J. Lerner
- P. Rosenberg
- Jamie Perin
- David Shade
- Myuri Ruthirakuhan
- Nathan Herrmann
- Anton P. Porsteinsson
- Krista L. Lanctôt
- Zahinoor Ismail
- Suzanne Craft
- Allan I. Levey
- Christopher H. van Dyck
Institutions
- Rutgers, The State University of New Jersey (US)
- Sunnybrook Health Science Centre (CA)
- Johns Hopkins University (US)
- Emory University (US)
- Medical University of South Carolina (US)
- University of Calgary (CA)
- University of Toronto (CA)
- Johns Hopkins Medicine (US)
- Yale University (US)
- Central Arkansas Veterans Healthcare System (US)
- Ralph H. Johnson VA Medical Center (US)
- University School (US)
- Sunnybrook Hospital (CA)
- Sunnybrook Research Institute
- Hotchkiss Brain Institute (CA)
- Wake Forest University (US)
- University of Rochester (US)
- Case Western Reserve University (US)
- University of Arkansas for Medical Sciences (US)
Publication Details
- Journal
- International Psychogeriatrics
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1016/j.inpsyc.2025.100181
- Primary Topic
- Traumatic Brain Injury Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00